nach oben

Erschienen in:

30.11.2021 | Original Article

Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors

verfasst von: Andrea Chirico, Deborah Vizza, Moira Valente, Melania Lo Iacono, Maria Rosita Campagna, Tommaso Palombi, Fabio Alivernini, Fabio Lucidi, Francesco Bruno

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The fear of cancer recurrence (FCR) is one of the most reported problems by cancer survivors. A valid instrument to detect this issue could be useful to identify cancer survivors who are more vulnerable to developing FCR and related adverse outcomes (e.g., anxiety). The present study aimed to evaluate FCR in a sample of Italian breast cancer survivors using an Italian version of the 8-item Cancer Worry Scale (CWS) in order to establish a cut-off for the use in clinical settings.

Methods

The participants were 119 breast cancer survivors (mean age 47.7 years) at least 1 year after their primary treatment. An exploratory factor analysis (EFA) of CWS, internal reliability of CWS, concurrent and divergent validity using a bivariate correlation between the key measures of the study (i.e., FCR, anxiety, depression, fatigue, and self-efficacy), and ROC analysis of CWS were performed.

Results

Fit indices for the EFA were considered acceptable and showed a two-factor structure-labeled cancer worries and worries impact. The reliability of the two factors showed a Cronbach’s alpha coefficient greater than 0.90. The CWS was positively related to anxiety, depression, fatigue, and negatively related to perceived self-efficacy. The best cut-off score was 24 versus 25, with a sensitivity of 74% and a specificity of 85%.

Conclusions

The CWS is a valid questionnaire to assess FCR among breast cancer survivors. The present study provides an overview of the relationship between CWS and the adverse outcomes related to FCR and coping strategies adopted to face it.

Winters S, Martin C, Murphy D, Shokar NK (2017) Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci 151:1–32. https://doi.org/10.1016/bs.pmbts.2017.07.002CrossRefPubMed

Italian Association of Cancer Registers (2019) I numeri del cancro in Italia. https://www.registritumori.it/cms/pubblicazioni/i-numeri-del-cancro-italia-2019

Lebel S et al (2017) Current state and future prospects of research on fear of cancer recurrence. Psychooncology. https://doi.org/10.1002/pon.4103CrossRefPubMed

Tauber NM et al (2019) Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. https://doi.org/10.1200/JCO.19.00572CrossRefPubMedPubMedCentral

Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C (2012) Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-Oncology. https://doi.org/10.1002/pon.2070CrossRefPubMed

Champion VL et al (2004) A breast cancer fear scale: psychometric development. J Health Psychol. https://doi.org/10.1177/1359105304045383CrossRefPubMed

Berrenberg JL (1991) The cancer attitude inventory: development and validation. J Psychosoc Oncol. https://doi.org/10.1300/J077v09n02_03CrossRef

Gramling R, Anthony D, Frierson G, Bowen D (2007) The cancer worry chart: a single-item screening measure of worry about developing breast cancer. Psychooncology. https://doi.org/10.1002/pon.1128CrossRefPubMed

Custers JAE, Van Den Berg SW, Van Laarhoven HWM, Bleiker EMA, Gielissen MFM, Prins JB (2014) The cancer worry scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs. https://doi.org/10.1097/NCC.0b013e3182813a17CrossRefPubMed

10.

Caruso A, Vigna C, Gremigni P (2018) The Cancer Worry Scale revised for breast cancer genetic counseling. Cancer Nurs. https://doi.org/10.1097/NCC.0000000000000511CrossRefPubMed

11.

Cabrera E, Zabalegui A, Blanco I (2011) Spanish version of the Cancer Worry Scale (CWS). Cross cultural adaptation and validity and reliability analysis. Med Clin (Barc). https://doi.org/10.1016/j.medcli.2010.04.015CrossRef

12.

Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1(16):171–176

13.

Watson M et al (1998) Family history of breast cancer: What do women understand and recall about their genetic risk? J Med Genet. https://doi.org/10.1136/jmg.35.9.731CrossRefPubMedPubMedCentral

14.

Douma KFL et al (2010) Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology. https://doi.org/10.1002/pon.1570CrossRefPubMed

15.

Van De Wal M, Thewes B, Gielissen M, Speckens A, Prins J (2017) Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. https://doi.org/10.1200/JCO.2016.70.5301CrossRefPubMed

16.

Custers JAE, Gielissen MFM, Janssen SHV, de Wilt JHW, Prins JB (2016) Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. https://doi.org/10.1007/s00520-015-2808-4CrossRefPubMedPubMedCentral

17.

Custers JAE, Tielen R, Prins JB, De Wilt JHW, Gielissen MFM, Van Der Graaf WTA (2015) Fear of progression in patients with gastrointestinal stromal tumors (GIST): is extended lifetime related to the Sword of Damocles? Acta Oncol (Madr). https://doi.org/10.3109/0284186X.2014.1003960CrossRef

18.

Thewes B et al (2018) Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. https://doi.org/10.1007/s00520-017-3975-2CrossRefPubMed

19.

Schneider K (2002) Counseling about cancer: Strategies for genetic counselors, 2nd edn. Wiley-Liss, New York

20.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand. https://doi.org/10.1111/j.1600-0447.1983.tb09716.xCrossRefPubMed

21.

Serpentini S et al (2019) Self-efficacy for coping: utility of the Cancer behavior inventory (Italian) for use in palliative care. BMC Palliat Care 18(1):1–9. https://doi.org/10.1186/s12904-019-0420-yCrossRef

22.

T. Rstudio (2020) "RStudio: Integrated Development for R.," Rstudio Team, PBC, Boston, MA URL http://www.rstudio.com/https://doi.org/10.1145/3132847.3132886

23.

Revelle W (2019) Psych: procedures for psychological, psychometric, and personality research. R package version 1.9.12. Retrieved from https://CRAN.R-project.org/package=psych

24.

Bernaards CA, Jennrich RI (2005) Gradient projection algorithms and software for arbitrary rotation criteria in factor analysis. Educ Psychol Meas. https://doi.org/10.1177/0013164404272507CrossRef

25.

S. Korkmaz, D. Goksuluk, and G. Zararsiz (2014) MVN: an R package for assessing multivariate normality. R J. https://doi.org/10.32614/rj-2014-031

26.

Horn JL (1965) A rationale and test for the number of factors in factor analysis. Psychometrika. https://doi.org/10.1007/BF02289447CrossRefPubMed

27.

Williams B, Onsman A, Brown T (2010) Exploratory factor analysis: a five-step guide for novices. J Emerg Prim Heal Care. https://doi.org/10.33151/ajp.8.3.93CrossRef

28.

Hu LT, Bentler PM (1999) Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. https://doi.org/10.1080/10705519909540118CrossRef

29.

Tavakol M, Dennick R (2011) Post-examination analysis of objective tests. Med Teach. https://doi.org/10.3109/0142159X.2011.564682CrossRefPubMed

30.

Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B (2018) Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale. Psychooncology. https://doi.org/10.1002/pon.4782CrossRefPubMed

31.

Chirico A et al (2017) A meta-analytic review of the relationship of cancer coping selfefficacy with distress and quality of life. Oncotarget 8(22):36800–36811. https://doi.org/10.18632/oncotarget.15758CrossRefPubMedPubMedCentral

32.

Servaes P, Verhagen S, Schreuder HWB, Veth RPH, Bleijenberg G (2003) Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manage. https://doi.org/10.1016/j.jpainsymman.2003.03.001CrossRefPubMed

33.

Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant. https://doi.org/10.1038/sj.bmt.1705624CrossRefPubMed

34.

American Cancer Society (2006) Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Natl. Acadmies Press, Washington DC

35.

Brandenbarg D, Berendsen AJ, de Bock GH (2017) Patients’ expectations and preferences regarding cancer follow-up care. Maturitas. https://doi.org/10.1016/j.maturitas.2017.07.001CrossRefPubMed

36.

Laporte C et al (2017) French women’s representations and experiences of the post-treatment management of breast cancer and their perception of the general practitioner’s role in follow-up care: a qualitative study. Heal Expect. https://doi.org/10.1111/hex.12518CrossRef

37.

Hodges LJ, Humphris GM (2009) Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology. https://doi.org/10.1002/pon.1346CrossRefPubMed

38.

Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A (1991) Psychological side effects of breast cancer screening. Health Psychol. https://doi.org/10.1037/0278-6133.10.4.259CrossRefPubMed

39.

Trask PC et al (2001) Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology. https://doi.org/10.1002/pon.510CrossRefPubMed

40.

Almeida SN, Elliott R, Silva ER, Sales CMD (2019) Fear of cancer recurrence: a qualitative systematic review and meta-synthesis of patients’ experiences. Clin Psychol Rev. https://doi.org/10.1016/j.cpr.2018.12.001CrossRefPubMed

Titel: Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors
verfasst von: Andrea Chirico
Deborah Vizza
Moira Valente
Melania Lo Iacono
Maria Rosita Campagna
Tommaso Palombi
Fabio Alivernini
Fabio Lucidi
Francesco Bruno
Publikationsdatum: 30.11.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 3/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06718-4

Neu im Fachgebiet Onkologie

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors